3 Biotech Stocks That Surged Last Week
Find out what's behind their big run-ups to see if they can make it happen again.
Marinus Pharmaceuticals
MRNS
MRNS
$3.14
-$0.07
-2.2%
Price as of September 22, 2020, 8:00 p.m. EDT
View Interactive MRNS Charts
MARINUS PHARMACEUT
Interactive Chart
News & Analysis: Marinus Pharmaceuticals
Why Marinus Pharmaceuticals Stock Skyrocketed 80% Higher Today
Investors are thrilled with the results from a late-stage clinical study of the company's only pipeline drug candidate.
Nasdaq Rises Despite Nikola Hit; Marinus Soars
The tech-heavy index is bouncing back from recent weakness.
Here's Why Marinus Pharmaceuticals Stock Is Collapsing Today
Wall Street is not sold on the latest clinical results.
Here's Why Marinus Pharmaceuticals Is Sinking Today
A secondary offering on the way isn't what investors wanted to hear.
Here's Why Marinus Pharmaceuticals Inc. Fell as Much as 20.1% Today
The small biopharma announced second-quarter 2018 results and gave a business update.
Here's Why Marinus Pharmaceuticals Rose as Much as 18.4% Today
The tiny biopharma is back on the upswing following an analyst upgrade.
Here's Why Marinus Pharmaceuticals Dropped as Much as 17.7% Today
The biopharma's slide continues -- for good reason this time.
3 Best Healthcare Stocks of 2017
The key to big gains last year? Start off small.
Why Mattel, Marinus Pharmaceuticals, and Northern Dynasty Minerals Slumped Today
Learn why these stocks fell in a strong market.
